News, Policy & Economics

How Transformative Tech & Renegade Retail Will Reform Healthcare

By Erik Goldman

The next wave of healthcare reform won’t be coming from the federal government, the insurance industry, the hospital systems, or medical academia. In fact, the driving forces already reshaping healthcare aren’t coming from within healthcare at all, but from the world’s biggest tech and finance companies on one side, and good old-fashioned grass-roots consumerism on the other.

Gottlieb Resignation Leaves Key Supplement Rules in Limbo

By Erik Goldman, Editor

FDA Commissioner Scott Gottlieb’s surprise resignation earlier this month sent shockwaves through the natural products industries. His departure at the end of March will leave two key aspects of dietary supplement regulation in limbo: the legality of CBD supplements, and the possibility of a major revision of the Dietary Supplement Health and Education Act (DSHEA).

Cannabis & Hemp: A Regulatory Update

By Erik Goldman, Editor

The year 2018 was a landmark in the history of hemp and cannabis in the US. It was the year the FDA approved the first natural cannabis-derived prescription drug, and Congress passed a Farm Bill that included provisions legalizing cultivation of, and interstate commerce in, low-THC hemp. But the laws and regulation around hemp and cannabis remain a confusing patchwork, and some states are taking regulatory actions that run counter to the new federal provisions.

Cannabis, Hemp, Marijuana: What's in a Name?

By Erik Goldman, Editor

Amid the current rage for all things cannabis, there is a lot of confusion about the terminology used to describe this plant and compounds extracted from it.

Part of that confusion arises from the Farm Bill of 2018, which changes some federal definitions. These changes have major implications for legal and regulatory policy.  Here’s a guide to common cannabis-related terms and their current definitions.

Migrants at the Border: US Citizens Head South for Cheap Medical Care

By Erik Goldman

There are a lot of anxious, needy people eager to cross the line that separates the US from Mexico. Go to the border towns of Southern California and Arizona, and you’ll see them--- US citizens heading south to Mexican clinics and farmacias, seeking lower cost surgeries and cheap meds.

Medical and pharmacy “tourism” to Mexico is a large and growing phenomenon, one that has received little attention amid the bitter political rancor over immigration policy and border control.